First Eagle Investment Management
Holding/activity history for Sanofi Aventis (SNY)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2023 Q4 | 254,328 | 0.03 | Add 4.18% | 0.00 | $49.73 |
| 2023 Q3 | 244,131 | 0.03 | Add 9.15% | 0.00 | $53.64 |
| 2023 Q2 | 223,673 | 0.03 | Add 16.89% | 0.00 | $53.90 |
| 2023 Q1 | 191,350 | 0.03 | Add 24.29% | 0.01 | $54.42 |
| 2022 Q4 | 153,949 | 0.02 | Add 22.29% | 0.00 | $48.43 |
| 2022 Q3 | 125,891 | 0.01 | Add 35.30% | 0.00 | $38.02 |
| 2022 Q2 | 93,046 | 0.01 | Add 38.85% | 0.00 | $50.03 |
| 2022 Q1 | 67,012 | 0.01 | Add 45.08% | 0.00 | $51.33 |
| 2021 Q4 | 46,189 | 0.01 | Add 117.98% | 0.01 | $50.10 |
| 2021 Q3 | 21,190 | 0.00 | Add 65.25% | 0.00 | $48.23 |
| 2021 Q2 | 12,823 | 0.00 | Add 1649.39% | 0.00 | $52.64 |
| 2021 Q1 | 733 | 0.00 | Add 99.18% | 0.00 | $49.11 |
| 2020 Q4 | 368 | 0.00 | Buy | 0.00 | $48.91 |